Recombinant human keratinocyte growth factor: successful treatment of severe, refractory hemorrhagic cystitis after allogeneic hematopoietic cell transplantation

Saved in:
Bibliographic Details
Published inBone marrow transplantation (Basingstoke) Vol. 49; no. 12; pp. 1550 - 1551
Main Authors Bhaskaran, S, Abu-Arja, R F, Abusin, G, Cabral, L, Nagle, K, Ahuja, S, Egler, R, Cooke, K R, Lazarus, H M
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.12.2014
Nature Publishing Group
Subjects
692/700/565
Antineoplastic Agents - therapeutic use
Bone marrow
Care and treatment
Case studies
Cell Biology
Child
Cystitis
Cystitis - etiology
Cystitis - therapy
Erythrocyte Transfusion
Female
Fibroblast Growth Factor 7 - therapeutic use
Growth factors
Hematology
Hematopoietic Stem Cell Transplantation - adverse effects
Hematopoietic stem cells
Hemorrhage
Hemorrhage - etiology
Hemorrhage - therapy
Hemorrhagic cystitis
Humans
Internal Medicine
Keratinocyte growth factor
Keratinocytes
letter-to-the-editor
Leukemia, Myeloid, Acute - therapy
Medicine
Medicine & Public Health
Oxygen - therapeutic use
Physiological aspects
Public Health
Recombinant Proteins - therapeutic use
Recurrence
Stem cell transplantation
Stem Cells
Transplantation
Transplantation, Homologous - adverse effects
Treatment Outcome
Online AccessGet full text

Cover

More Information
ISSN:0268-3369
1476-5365
DOI:10.1038/bmt.2014.205